Pierre Van Mol
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 5
- Cancer Immunotherapy and Biomarkers 3
- Lung Cancer Research Studies 1
- Pancreatic and Hepatic Oncology Research 1
-
- COVID-19 Clinical Research Studies 2
- Co-authors
- Els Wauters (8 shared papers)Johan Vansteenkiste (2 shared papers)C. Van De Kerkhove (1 shared paper)Dirk De Ruysscher (1 shared paper)Bart Reymen (1 shared paper)Lizza Hendriks (1 shared paper)Solange Peters (1 shared paper)Francesco Cortiula (1 shared paper)
- Journals
- Annals of Oncology (2 papers)Journal for ImmunoTherapy of Cancer (1 paper)International review of cell and molecular biology (1 paper)Cellular and Molecular Life Sciences (1 paper)Expert Review of Anticancer Therapy (1 paper)
- Partner nations
- BelgiumSwitzerlandBrazil
In The Last Decade
Pierre Van Mol
9 papers receiving 248 citations
Peers
Comparison fields: 5 of 52
- Oncology 88
- Pulmonary and Respiratory Medicine 75
- Infectious Diseases 43
- Immunology 34
- Neurology 23
Countries citing papers authored by Pierre Van Mol
This map shows the geographic impact of Pierre Van Mol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Van Mol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Van Mol more than expected).
Fields of papers citing papers by Pierre Van Mol
This network shows the impact of papers produced by Pierre Van Mol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Van Mol. The network helps show where Pierre Van Mol may publish in the future.
Co-authors
The 25 scholars most cited alongside Pierre Van Mol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 68 | |
| 2 | 2022 | 66 | |
| 3 | 2020 | 59 | |
| 4 | 2022 | 43 | |
| 5 | 2023 | 6 | |
| 6 | 2020 | 3 | |
| 7 | 2021 | 2 | |
| 8 | 2022 | 2 | |
| 9 | 2023 | 1 | |
| 10 | 2018 | 0 |
About Pierre Van Mol
Pierre Van Mol is a scholar working on Oncology, Infectious Diseases, Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine and Epidemiology, having authored 10 papers that have together received 250 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Ultrasound in Clinical Applications (2 papers), COVID-19 Clinical Research Studies (2 papers), Cancer Mechanisms and Therapy (1 paper), Parkinson's Disease and Spinal Disorders (1 paper), Lung Cancer Research Studies (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Respiratory Support and Mechanisms (1 paper). The work is most often cited by research in Oncology (88 citations), Pulmonary and Respiratory Medicine (75 citations), Infectious Diseases (43 citations), Immunology (34 citations) and Neurology (23 citations). Pierre Van Mol has collaborated with scholars based in Belgium, Switzerland and Brazil. Frequent co-authors include Els Wauters, Johan Vansteenkiste, C. Van De Kerkhove, Dirk De Ruysscher, Bart Reymen, Lizza Hendriks, Solange Peters, Francesco Cortiula, Stéphanie Humblet‐Baron and Joost Wauters. Their work appears in journals such as Annals of Oncology, Journal for ImmunoTherapy of Cancer, International review of cell and molecular biology, Cellular and Molecular Life Sciences and Expert Review of Anticancer Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.